Skip to main content
Top
Published in: Supportive Care in Cancer 12/2006

01-12-2006 | Original Article

Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey

Authors: Sultan Kav, Humeyra Bostanci

Published in: Supportive Care in Cancer | Issue 12/2006

Login to get access

Abstract

Introduction

The goal of this study was to identify the nursing role in providing education and follow-ups of patients who were taking oral chemotherapy (CT) treatment in oncology clinics in Turkey. This study arises from the fact that an increasing number of oral CT agents are being developed and used in clinical practice.

Methods

One hundred and two nurses from various centers completed a 16-item questionnaire.

Results

Nearly half of the nurses work in outpatient/ambulatory clinics (46.1%); the most commonly used oral CT agents were etoposide, capecitabine, methotrexate, hydroxyurea, melphalan, and uracil plus tegafur; 86.3% of the nurses had not received any education on the oral drugs; 72.6% of the nurses stated there was no guideline/protocol for oral CT administration in their unit; and 91.2% of the subjects reported the lack of educational materials specifically for oral CT agents. Half of the subjects reported providing some patient education, mostly giving information about “timing,” among them 42.3% reported not giving any information on drug safety, side effects, or symptom management. The reasons for the nurses not being involved in oral CT education and follow-ups were because the physicians plan oral CT and follow-ups of the patients and because of a lack of knowledge.

Conclusions

Nurses and physicians describe the role of the nurse as “giving intravenous CT.” Given that the number of oral CT agents is on the rise, nurses must begin to take an active role in patient education and follow-up.
Literature
1.
go back to reference Bedell CH (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):5–9PubMed Bedell CH (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):5–9PubMed
2.
go back to reference Birner A (2003) Pharmacology of oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):1–5 Birner A (2003) Pharmacology of oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):1–5
3.
go back to reference Birner A (2003) Safe administration of oral chemotherapy. Clin J Oncol Nurs 7:158–162PubMed Birner A (2003) Safe administration of oral chemotherapy. Clin J Oncol Nurs 7:158–162PubMed
4.
go back to reference Borner M, Schithauer W, Twelves C, Maroun J, Wilke H (2001) Answering patients’ needs: oral alternatives to intravenous therapy. Oncologist 6(Suppl 4):12–16PubMedCrossRef Borner M, Schithauer W, Twelves C, Maroun J, Wilke H (2001) Answering patients’ needs: oral alternatives to intravenous therapy. Oncologist 6(Suppl 4):12–16PubMedCrossRef
5.
go back to reference Chau I, Legge S, Fumoleau P (2004) The vital role of education and information in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs 8(Suppl 1):41–53CrossRef Chau I, Legge S, Fumoleau P (2004) The vital role of education and information in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs 8(Suppl 1):41–53CrossRef
6.
go back to reference Gerbrecht BM, Kangas T (2004) Implications of capecitabine (Xeloda) for cancer nursing practice. Eur J Oncol Nurs 8(Suppl 1):63–71CrossRef Gerbrecht BM, Kangas T (2004) Implications of capecitabine (Xeloda) for cancer nursing practice. Eur J Oncol Nurs 8(Suppl 1):63–71CrossRef
7.
go back to reference Griffin E (2003) Safety considerations and safe handling of oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):25–29PubMed Griffin E (2003) Safety considerations and safe handling of oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):25–29PubMed
8.
go back to reference Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21–24PubMed Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21–24PubMed
9.
go back to reference Hayden BK, Goodman M (2005) Chemotherapy: principles of administration. In: Yarbro CH, Frogge MH, Goodman M (eds) Cancer nursing principles and practice, 6th edn. Jones and Bartlett, Sudbury, pp 359–360 Hayden BK, Goodman M (2005) Chemotherapy: principles of administration. In: Yarbro CH, Frogge MH, Goodman M (eds) Cancer nursing principles and practice, 6th edn. Jones and Bartlett, Sudbury, pp 359–360
10.
go back to reference Hollywood E, Semple D (2001) Nursing strategies for patients on oral chemotherapy. Oncology 15(Suppl 2):37–40PubMed Hollywood E, Semple D (2001) Nursing strategies for patients on oral chemotherapy. Oncology 15(Suppl 2):37–40PubMed
11.
go back to reference Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Meese MR (1990) Patient noncompliance with self-administered chemotherapy. Cancer 65:17–22PubMedCrossRef Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Meese MR (1990) Patient noncompliance with self-administered chemotherapy. Cancer 65:17–22PubMedCrossRef
12.
go back to reference Levine AM, Richardson JL, Marks G, Chan K, Graham J, Selser JN et al (1987) Compliance with oral drug therapy in patients with hematologic malignancies. J Clin Oncol 5:1469–1476PubMed Levine AM, Richardson JL, Marks G, Chan K, Graham J, Selser JN et al (1987) Compliance with oral drug therapy in patients with hematologic malignancies. J Clin Oncol 5:1469–1476PubMed
13.
go back to reference Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15:110–115PubMed Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15:110–115PubMed
14.
go back to reference McLeod HL, Evans WE (1999) Oral cancer chemotherapy: the promise and the pitfalls. Clin Cancer Res 5(10):2669–2671PubMed McLeod HL, Evans WE (1999) Oral cancer chemotherapy: the promise and the pitfalls. Clin Cancer Res 5(10):2669–2671PubMed
15.
go back to reference McPherson CJ, Higginson IJ, Hearn J (2001) Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med 23:227–234PubMedCrossRef McPherson CJ, Higginson IJ, Hearn J (2001) Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med 23:227–234PubMedCrossRef
16.
go back to reference O’Neill VJ, Twelves CJ (2002) Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer 87:933–937PubMedCrossRef O’Neill VJ, Twelves CJ (2002) Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer 87:933–937PubMedCrossRef
17.
go back to reference Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652–661PubMed Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652–661PubMed
18.
go back to reference Sharma S (2001) Patient selection for oral chemotherapy. Oncology 15(Suppl 2):33–35PubMed Sharma S (2001) Patient selection for oral chemotherapy. Oncology 15(Suppl 2):33–35PubMed
19.
go back to reference van Eijken M, Tsang S, Wensing M, de Smet PA, Grol RP (2003) Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 20(3):229–240PubMedCrossRef van Eijken M, Tsang S, Wensing M, de Smet PA, Grol RP (2003) Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 20(3):229–240PubMedCrossRef
Metadata
Title
Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey
Authors
Sultan Kav
Humeyra Bostanci
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 12/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0084-z

Other articles of this Issue 12/2006

Supportive Care in Cancer 12/2006 Go to the issue

Forthcoming Meetings

Forthcoming Meetings

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine